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Introduction
Neurological disturbances and acute kidney injury (AKI)
commonly co-exist in critically ill patients. However, it
is unclear if AKI directly contributes to neurological dis-
turbances (uremic encephalopathy) or if neurological
disturbances and AKI are both reflections of multi-
organ failure. Furthermore, it is unclear if renal replace-
ment therapy (RRT) improves outcome, especially if
other indications for RRT are absent.
Objectives
To analyze the incidence, characteristics, effect of RRT, and
outcomes in patients with neurological disturbances and
AKI.
Methods
During the study-period 2012-2013 at an university hospi-
tal intensive care unit (ICU) in The Netherlands, we retro-
spectively reviewed all neurology consults (n = 803) and
then selected patients with concomitant AKI. Patients
with intracranial pathology were excluded. After detailed
analysis by a neurologist and nephrologist, patients were
classified as neurological disturbances with AKI (NWH,
neurological status attributable to several causes, including
AKI) or neurological disturbances due to AKI (NDA, no
other explanation for the neurological status than AKI).
Results
The incidence of neurological disturbances and AKI was
6.6 per 1,000 ICU admissions (95% CI 4.7 - 9.1). Of the
35 patients with neurological disturbances and AKI,
NWA was four times more common than NDA (28 vs. 7
patients). Patients with NDA were more uremic (serum
urea 42 vs. 23 mmol/l, p = 0.005), but had lower sequen-
tial organ failure (SOFA) scores (11.6 vs. 13.8, p = 0.04).
RRT was started in 71% of NDA cases (in two patients
coma was the only indication) and in 46% of NWA cases
(p = 0.2). 28-day mortality was 57% in the NDA cases
and 82% in the NWA cases (p = 0.2). Patients receiving
RRT did not have better outcomes than patients not
receiving RRT (neurological improvement 33 vs. 41%; 28-
day mortality 83 vs. 69%; p > 0.05 for both).
Conclusions
In critically ill patients with neurological disturbances
and AKI, AKI is usually only one of the possible factors
contributing to the neurological status. The combination
of AKI and neurological disturbances signals a poor
prognosis with RRT having little effect on neurological
improvement or mortality.
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